Sales and Marketing

Showing 15 posts of 11524 posts found.

NICE decides to back Abilify in schizophrenia

January 27, 2011 Sales and Marketing Abilify, BMS, Bristol-Myers Squibb, NICE, Otsuka, aripiprazole, schizophrenia

NICE has changed its mind over Bristol-Myers Squibb’s and Otsuka Pharmaceuticals Abilify, deciding to recommend the drug as a schizophrenia …

Double Helix Consulting expands

January 26, 2011 Sales and Marketing Clara Loveman, Double Helix, Dr Clive Whitcher, Dr Laurence Wild, appointment, sales and marketing

Double Helix Consulting has appointed three new executives to its growing global team – Clara Loveman, Dr Clive Whitcher and …

J&J posts negative growth as pharma sales stall

January 26, 2011 Sales and Marketing 2010 pharma results, J&J, JJ, Johnson and Johnson, Remicade, Risperdal Consta

Falling fourth quarter sales of Risperdal Consta and Remicade capped a year to forget for Johnson and Johnson. The company’s …

Eisai sepsis drug fails in phase III

January 26, 2011 Research and Development, Sales and Marketing Eisai, eritoran, perampanel, sepsis

A new treatment for severe sepsis could be abandoned entirely after phase III results fell short. Eisai’s eritoran did not …

Novartis MS drug steals march over Merck rival

January 24, 2011 Sales and Marketing Cladribine, MS, Merck KGaA, Novartis, fingolimod, gilenya, multiple sclerosis

Novartis’ oral multiple sclerosis Gilenya could be on the European market in just three months after winning the backing of …

Novartis offers $470m to boost personalised cancer treatment

January 24, 2011 Research and Development, Sales and Marketing Cancer, Genoptix, Novartis, cancer diagnostics, personalised medicine

Novartis has offered $470 million for a California-based laboratory whose diagnostic services it hopes will enhance personalised treatment. Genoptix specialises …
ABPI

ABPI warns of postcode prescribing

January 21, 2011 Sales and Marketing ABPI, Cancer Drugs Fund, NICE, cancer drug prescribing, postcode prescribing

The ABPI has said the government’s forthcoming Cancer Drugs Fund could increase the problems of postcode prescribing. The UK industry …

Health Bill continues fast pace of NHS reform

January 20, 2011 Sales and Marketing GP consortia, NHS, NHS Commissioning Board, NHS reforms, NICE, QALY

The government has outlined its draft Health and Social Care Bill, making some minor concessions to critics but promising no …

Caution raised on statins in healthy people

January 20, 2011 Sales and Marketing Cochrane, Crestor, Lipitor, statin, statin prescribing

Researchers have warned of a lack of evidence to support prescribing statins in patients at low risk of developing heart …

Key drug launches for 2011

January 20, 2011 Sales and Marketing Benlysta, Cladribine, Movectro, Pradaxa, Xarelto, axitinib, boceprevir, crizotinib, telaprevir

This year is expected to see new treatments for hepatitis C, multiple sclerosis and lupus among those that could reach …

Cancer Drugs Fund must not be forerunner to value-based pricing – EMIG

January 19, 2011 Sales and Marketing Cancer Drugs Fund, EMIG, Ethical Medicines Industry Group, NHS, value-based pricing

The association representing small to medium UK pharma companies says the forthcoming Cancer Drugs Fund is welcome – but must …

EMA’s Thomas Lönngren joins market access firm

January 19, 2011 Research and Development, Sales and Marketing NDA Group, Thomas Lönngren, appointment, recruitment, research and development, sales and marketing

The former head of the EMA Thomas Lönngren has taken up a post at new European regulatory and market access …

Sanofi ‘considering’ raising Genzyme offer

January 19, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, pharma mergers and acquisitions

Sanofi-Aventis could be willing to raise its offer to $76 a share to buy the US biotech firm Genzyme, according …

Online physician communities in UK and France join forces

January 19, 2011 Medical Communications, Sales and Marketing Egora, Global Media Sante, doctors communities, doctors.net, online communities

Two online communities for doctors have launched a strategic alliance to help them expand their reach. UK-based Doctors.net.uk is teaming …

European Commission launches new generic deal review

January 18, 2011 Sales and Marketing European Commission, anti-trust investigation, competition, generics

The European Commission has asked a number of firms to submit copies of their patent settlements in 2010 to see …
The Gateway to Local Adoption Series

Latest content